Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Study to Estimate Seedchrony's Predictive Capacity in the Success of Embryo Implantation.

NCT: NCT06259084 · COMPLETED

NCT IDNCT06259084
StatusCOMPLETED
Start Date2024-02-28
Completion2026-04-26
SponsorManina Medtech (INDUSTRY)
First posted
Last updated

Brief Summary

In Vitro Fertilization (IVF) success is below 40%, with Embryo Transfer the leading cause of IVF failure. This clinical investigation aims to evaluate if the levels of an intrauterine biomarker dissolved in the uterine fluid (alone or as a complex biological marker) can predict the outcome of embryo transfer.

Frequently Asked Questions

What is Study to Estimate Seedchrony's Predictive Capacity in the Success of Embryo Implantation.?

Study to Estimate Seedchrony's Predictive Capacity in the Success of Embryo Implantation. is a clinical trial registered under NCT06259084. Current status: COMPLETED.

What is the status of NCT06259084?

The current status of NCT06259084 (Study to Estimate Seedchrony's Predictive Capacity in the Success of Embryo Implantation.) is: COMPLETED.

When did Study to Estimate Seedchrony's Predictive Capacity in the Success of Embryo Implantation. start?

Study to Estimate Seedchrony's Predictive Capacity in the Success of Embryo Implantation. started on 2024-02-28.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.